Sucrose Analgesia in Infants Undergoing Casting for Club Foot

NCT ID: NCT01050088

Last Updated: 2010-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Babies with congenital clubfeet are treated by the Ponseti casting method. The procedure may cause discomfort to the patient. This study will examine the use of 5 CC Sucrose solution as a comforting agent for the babies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Babies who were born with congenital clubfeet are currently being treated by the conventional Ponseti method. This procedure is done in an outpatient clinic setup. The procedure is painless but may cause some discomfort to the patient. This study will examine the use of 5 CC Sucrose solution as a comforting agent for the babies. The control group will consist of patients who will get 5cc saline pre cast application, while the study group will be given 5cc of Sucrose solution. Patients and physicians are blinded to the treatment they get. Outcome measures will include pulse rate and oxygenation as an accepted measure of discomfort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clubfoot

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sucrose

5cc sucrose solution

Group Type EXPERIMENTAL

sucrose solution

Intervention Type DIETARY_SUPPLEMENT

5cc 5% sucrose solution P/O

Saline

5cc saline p/o

Group Type PLACEBO_COMPARATOR

Saline

Intervention Type DIETARY_SUPPLEMENT

5cc saline p/o

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sucrose solution

5cc 5% sucrose solution P/O

Intervention Type DIETARY_SUPPLEMENT

Saline

5cc saline p/o

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

5cc Saline solution

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All otherwise healthy babies who need casting for congenital clubfeet

Exclusion Criteria

* All non idiopathic conditions for clubfoot, all individuals who have any kind of known systemic illness, all babies born to diabetic mothers.
Minimum Eligible Age

4 Weeks

Maximum Eligible Age

12 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rabin Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Schneider Children's MedicalCenter in Israel

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Danielw M Weigl, MD

Role: PRINCIPAL_INVESTIGATOR

Schneider Children's Medical Center

Kalman Katz, Prof.

Role: STUDY_DIRECTOR

Schneider Children's Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Schneider Children's Medical Center

Petah Tikva, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel M Weigl, MD

Role: CONTACT

972-3-9253759

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Daniel M Weigl, MD

Role: primary

972-3-9253759

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

005411

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.